Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus

    Bressler, B; Marshall, J. K; Bernstein, C. N; Bitton, A; Jones, J; Leontiadis, G. I; Panaccione, R; Steinhart, A. H; Tse, F; Feagan, B.
    Gastroenterology; 148 (5), 2015
    BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
    Colitis Ulcerosa/tratamiento farmacológico, Atención Ambulatoria, Mesalamina/uso terapéutico, Corticoesteroides/uso terapéutico, Probióticos/uso terapéutico
    Texto completo

    World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics

    Fiocchi, A; Pawankar, R; Cuello-Garcia, C; Ahn, K; Al-Hammadi, S; Agarwal, A; Beyer, K; Burks, W; Canonica, G. W; Ebisawa, M; Gandhi, S; Kamenwa, R; Lee, B. W; Li, H; Prescott, S; Riva, J. J; Rosenwasser, L; Sampson, H; Spigler, M; Terracciano, L; Vereda-Ortiz, A; Waserman, S; Yepes-Nuñez, J. J; Brożek, J. L; Schünemann, H. J.
    World Allergy Organ. J; 8 (1), 2015
    BACKGROUND: Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20-30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence developm...
    Hipersensibilidad/prevención & control, Probióticos/administración & dosificación, Eccema/prevención & control
    Texto completo (enlace principal)     Texto completo (enlace alternativo)